share_log

There May Be Some Bright Spots In Shanghai Haoyuan Chemexpress' (SHSE:688131) Earnings

There May Be Some Bright Spots In Shanghai Haoyuan Chemexpress' (SHSE:688131) Earnings

上海好源化试( SHSE: 688131 ) 的收益可能有一些亮点
Simply Wall St ·  09/04 18:32

Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) stock was strong despite it releasing a soft earnings report last week. However, we think the company is showing some signs that things are more promising than they seem.

上海豪远化工(SHSE:688131)的股票尽管上周发布了一份业绩较弱的报告,但表现依然强劲。然而,我们认为该公司显示出一些迹象,表明情况可能比看上去更有前景。

big
SHSE:688131 Earnings and Revenue History September 4th 2024
SHSE:688131 历史数据开始于2024年9月4日的营业收入和收益。

The Impact Of Unusual Items On Profit

除了稀释之外,还应该注意的是,万集科技在过去12个月中因不寻常项目获得了价值人民币3.5万元的利润。虽然我们希望看到利润增加,但当这些不寻常项目对利润做出重大贡献时,我们会更加谨慎。我们对全球大部分上市公司的数据进行了分析,发现不寻常项目往往是一次性的。这正如我们所期望的那样,因为这些提升被描述为"不寻常"。相对于其利润而言,万集科技在2021年12月前的不寻常项目贡献大。因此,我们可以推断出,这些不寻常项目正在使其财务利润显著增强。

To properly understand Shanghai Haoyuan Chemexpress' profit results, we need to consider the CN¥40m expense attributed to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. If Shanghai Haoyuan Chemexpress doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.

为了正确认识上海豪远化工的利润结果,我们需要考虑到归因于飞凡项目的4千万人民币的费用。看到飞凡项目影响公司利润并不理想,但好消息是,情况可能很快就会好转。我们调查了成千上万家上市公司,并发现飞凡项目很常常是一次性的。鉴于这些项目被视为飞凡,这几乎不足为奇。如果上海豪远化工不再出现这些飞凡费用,其他条件不变的情况下,我们预计其利润会在接下来的一年里增加。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

这可能会让您想知道分析师对未来盈利能力的预测。幸运的是,您可以单击此处查看基于其估计的未来盈利能力的互动图表。

Our Take On Shanghai Haoyuan Chemexpress' Profit Performance

我们对上海豪远化工的盈利表现的看法

Unusual items (expenses) detracted from Shanghai Haoyuan Chemexpress' earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Shanghai Haoyuan Chemexpress' statutory profit actually understates its earnings potential! Unfortunately, though, its earnings per share actually fell back over the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. So while earnings quality is important, it's equally important to consider the risks facing Shanghai Haoyuan Chemexpress at this point in time. For example - Shanghai Haoyuan Chemexpress has 3 warning signs we think you should be aware of.

飞凡项目(费用)削减了上海好源化学快递过去一年的收益,但我们可能会在明年看到改善。 根据这个观察,我们认为上海好源化学快递的法定利润实际上低估了其收益潜力! 不幸的是,它的每股收益在过去一年实际上有所下滑。 当然,我们在分析其收益方面只是刚刚开始钻研表面; 可以考虑的因素还有利润率、预测增长和投资回报等等。 所以虽然盈利质量很重要,但同样重要的是考虑上海好源化学快递当前面临的风险。 例如 - 上海好源化学快递有3个警示信号,我们认为你应该意识到。

Today we've zoomed in on a single data point to better understand the nature of Shanghai Haoyuan Chemexpress' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

今天我们放大了一个数据点,以更好地了解上海好源化学快递的利润性质。 但如果你能将注意力集中在细节上,就能发现更多的东西。 例如,很多人认为高股本回报率是良好企业经济的标志,而其他人则喜欢“跟随资金”并寻找内部人员在买入的股票。 虽然这可能需要你进行一些研究,但你可能会发现这个免费的公司收藏中有很多具有高股本回报率的公司,或者这个持有内部人员大量股票的股票列表会有所帮助。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发